S. AKAR Et Al. , "A Nationwide Experience with the Off Label Use of Interleukin 1 Targeting Treatment in Familial Mediterranean Fever Patients," ARTHRITIS & RHEUMATOLOGY , vol.68, 2016
AKAR, S. Et Al. 2016. A Nationwide Experience with the Off Label Use of Interleukin 1 Targeting Treatment in Familial Mediterranean Fever Patients. ARTHRITIS & RHEUMATOLOGY , vol.68 .
AKAR, S., Cetin, P., KALYONCU, U., KARADAĞ, Ö., Sari, I., Cinar, M., ... Yilmaz, S.(2016). A Nationwide Experience with the Off Label Use of Interleukin 1 Targeting Treatment in Familial Mediterranean Fever Patients. ARTHRITIS & RHEUMATOLOGY , vol.68.
AKAR, SERVET Et Al. "A Nationwide Experience with the Off Label Use of Interleukin 1 Targeting Treatment in Familial Mediterranean Fever Patients," ARTHRITIS & RHEUMATOLOGY , vol.68, 2016
AKAR, SERVET Et Al. "A Nationwide Experience with the Off Label Use of Interleukin 1 Targeting Treatment in Familial Mediterranean Fever Patients." ARTHRITIS & RHEUMATOLOGY , vol.68, 2016
AKAR, S. Et Al. (2016) . "A Nationwide Experience with the Off Label Use of Interleukin 1 Targeting Treatment in Familial Mediterranean Fever Patients." ARTHRITIS & RHEUMATOLOGY , vol.68.
@article{article, author={SERVET AKAR Et Al. }, title={A Nationwide Experience with the Off Label Use of Interleukin 1 Targeting Treatment in Familial Mediterranean Fever Patients}, journal={ARTHRITIS & RHEUMATOLOGY}, year=2016}